Marketdash
Back to News

T-Mobile Gets a Second Look: Five Analyst Upgrades Worth Watching

MarketDash Editorial Team
6 days ago
Wall Street analysts are changing their minds on several prominent stocks, including T-Mobile US, which just shed its bearish rating. From telecom to theme parks, here's who's getting upgraded and what price targets come with the new optimism.

Sometimes the most interesting analyst moves aren't the ones screaming "Buy!" at the top of their lungs, but rather the ones quietly backing away from previous skepticism. That's what happened Tuesday when several Wall Street analysts shifted their stances on a handful of notable companies.

T-Mobile Sheds Its Bearish Label

The headline move came from Keybanc analyst Brandon Nispel, who upgraded T-Mobile US Inc (TMUS) from Underweight to Sector Weight. That's Wall Street speak for "we no longer think this stock will underperform." While it's not exactly a ringing endorsement, it marks a meaningful shift in sentiment. T-Mobile shares closed at $206.63 on Monday.

Medical Spinoff Gets Some Love

BTIG analyst Ryan Zimmerman is considerably more enthusiastic about Solventum Corp (SOLV), upgrading the medical technology company from Neutral to Buy with a $100 price target. That suggests decent upside from Monday's closing price of $85.56. Solventum, if you're keeping track, is the 3M spinoff that handles healthcare products.

Mixed Signals at the Theme Park

Here's an interesting one: Truist Securities analyst Michael Swartz upgraded Six Flags Entertainment Corp (FUN) from Hold to Buy, but simultaneously slashed the price target from $27 down to $23. Given that the stock closed at $14.87 on Monday, that still implies substantial upside, even if expectations have been trimmed. Sometimes being less wrong is the path to being right.

Ingredients for Success?

TD Cowen analyst Jason Gabelman is feeling considerably more optimistic about Darling Ingredients Inc (DAR), upgrading the stock from Hold to Buy while boosting the price target from $34 all the way to $45. That's a meaningful vote of confidence for the sustainable ingredients company, whose shares closed at $36.77 on Monday.

Lithium Producer Moves to Neutral Ground

Rounding out Tuesday's upgrades, Baird analyst Ben Kallo moved Albemarle Corp (ALB) from Underperform to Neutral, raising the price target from $81 to $113. It's worth noting that Albemarle shares closed at $128.33 on Monday, already trading above the new target. The lithium producer has apparently moved faster than analyst expectations could keep up.

These rating changes reflect shifting analyst sentiment across diverse sectors, from telecommunications and healthcare to entertainment and materials. Whether these upgrades prove prescient or premature, they offer a snapshot of where some Wall Street analysts see value emerging.

Back to News

T-Mobile Gets a Second Look: Five Analyst Upgrades Worth Watching

MarketDash Editorial Team
6 days ago
Wall Street analysts are changing their minds on several prominent stocks, including T-Mobile US, which just shed its bearish rating. From telecom to theme parks, here's who's getting upgraded and what price targets come with the new optimism.

Sometimes the most interesting analyst moves aren't the ones screaming "Buy!" at the top of their lungs, but rather the ones quietly backing away from previous skepticism. That's what happened Tuesday when several Wall Street analysts shifted their stances on a handful of notable companies.

T-Mobile Sheds Its Bearish Label

The headline move came from Keybanc analyst Brandon Nispel, who upgraded T-Mobile US Inc (TMUS) from Underweight to Sector Weight. That's Wall Street speak for "we no longer think this stock will underperform." While it's not exactly a ringing endorsement, it marks a meaningful shift in sentiment. T-Mobile shares closed at $206.63 on Monday.

Medical Spinoff Gets Some Love

BTIG analyst Ryan Zimmerman is considerably more enthusiastic about Solventum Corp (SOLV), upgrading the medical technology company from Neutral to Buy with a $100 price target. That suggests decent upside from Monday's closing price of $85.56. Solventum, if you're keeping track, is the 3M spinoff that handles healthcare products.

Mixed Signals at the Theme Park

Here's an interesting one: Truist Securities analyst Michael Swartz upgraded Six Flags Entertainment Corp (FUN) from Hold to Buy, but simultaneously slashed the price target from $27 down to $23. Given that the stock closed at $14.87 on Monday, that still implies substantial upside, even if expectations have been trimmed. Sometimes being less wrong is the path to being right.

Ingredients for Success?

TD Cowen analyst Jason Gabelman is feeling considerably more optimistic about Darling Ingredients Inc (DAR), upgrading the stock from Hold to Buy while boosting the price target from $34 all the way to $45. That's a meaningful vote of confidence for the sustainable ingredients company, whose shares closed at $36.77 on Monday.

Lithium Producer Moves to Neutral Ground

Rounding out Tuesday's upgrades, Baird analyst Ben Kallo moved Albemarle Corp (ALB) from Underperform to Neutral, raising the price target from $81 to $113. It's worth noting that Albemarle shares closed at $128.33 on Monday, already trading above the new target. The lithium producer has apparently moved faster than analyst expectations could keep up.

These rating changes reflect shifting analyst sentiment across diverse sectors, from telecommunications and healthcare to entertainment and materials. Whether these upgrades prove prescient or premature, they offer a snapshot of where some Wall Street analysts see value emerging.